Romanian Review of Laboratory Medicine最新文献

{"title":"Co-expression of the CBFβ-MYH11 and BCR-ABL fusion genes in chronic myeloid leukaemia / Coexistenţa genelor de fuziune CBFβ-MYH11 şi BCR-ABL în leucemia mieloidă cronică","authors":"R. Popescu, A. Dascalescu, C. Dǎnǎilǎ, Doramina Ghiorghiu, M. Zlei, A. Ivanov, A. Sireteanu, E. V. Gorduza, D. Azoicǎi","doi":"10.1515/rrlm-2015-0013","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0013","url":null,"abstract":"Abstract The coexistence of t(9;22) and inv(16) has been described in a very limited number of cases of CML, de novo or therapy-related AML. We report a patient with CML who presented both inversion of chromosome 16 and Philadelphia chromosome and evolved towards the blast phase under treatment with Imatinib. Laboratory diagnosis and monitoring was made by flow cytometry, conventional cytogenetics and molecular genetics techniques. The inv(16), detected by karyotyping in the Philadelphia chromosome positive clone at the moment of the blast transformation, was retrospectively assessed by means of real-time PCR, and was proved to have been present since diagnosis. The bone marrow biopsy performed in the blast phase of CML confirmed the presence of blasts belonging to the myeloid lineage, with indications of monocytic differentiation, frequently associated with inv(16). Moreover, the case also associated a F359V tyrosine kinase domain mutation, resulting in intermediate resistance to Imatinib and Nilotinib, which imposed therapy-switch to Dasatinib. In our case the evolution was progressive, followed by death due to lack of response to tyrosine kinase inhibitors, 18 months after diagnosis. The coexistence of t(9;22) and inv(16) in CML seems to be associated with an aggressive clinical evolution and resistance to tyrosine kinase inhibitor therapy. Due to the very small number of cases described in literature, therapeutic decisions are still difficult for patients displaying these abnormalities Rezumat Coexistenţa t(9;22) şi a inv(16) a fost descrisă într-un număr limitat de cazuri de LMC, LAM de novo sau LAM post chimioterapie. Raportăm un pacient cu LMC care a prezentat atât inversie de 16 cât şi cromozom Philadelphia şi care a evoluat spre criză blastică sub tratament cu Imatinib. Diagnosicul de laborator şi monitorizarea s-a realizat prin citometrie în flux, citogenetică convenţională şi tehnici de genetică moleculară. Inv(16), detectată prin cariotipare în clona Philadelphia pozitivă la momentul transformării blastice, a fost evaluată retrospective prin metoda real-time PCR, şi s-a dovedit a fi fost prezentă încă de la diagnostic. Biopsia de măduvă osoasă, efectuată în faza blastică a LMC, a confirmat prezenţa blaştilor aparţinând liniei mieloide, cu indicii de diferenţiere monocitoidă, frecvent asociată cu inv (16). De asemenea, cazul a asociat şi mutaţia F359V în domeniul kinazic al ABL, care determină rezistenţă intermediară la Imatinib şi Nilotinib, ceea ce a impus schimbarea terapiei cu Dasatinib. În cazul prezentat evoluţia a fost progresivă, urmată de deces ca urmare a lipsei de răspuns la inhibitorii de tirozin kinază, la 18 luni de la diagnosticare. Coexistenţa t(9; 22) şi inv(16) în LMC pare a fi asociată cu o evoluţie clinică agresivă şi rezistenţă la terapia cu inhibitori de tirozin kinază. Având în vedere numărul foarte mic de cazuri descrise în literatura de specialitate, deciziile terapeutice în cazul pacienţilor care prezintă aces","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"129033762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Thirty years in hemostasis research in Cluj Napoca","authors":"M. Cucuianu","doi":"10.1515/rrlm-2015-0023","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0023","url":null,"abstract":"","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116028267","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Association of “cup-like” blasts morphology with NPM1 mutation in acute myeloid leukemia","authors":"N. Berbec, A. Lupu, S. Angelescu, Diana Mandescu, M. Bari","doi":"10.1515/rrlm-2015-0021","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0021","url":null,"abstract":"","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"35 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"134309361","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Factors influencing vitamin K antagonists therapy / Factori care influențează terapia cu antagoniști ai vitaminei K","authors":"I. Brudașcă","doi":"10.1515/rrlm-2015-0015","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0015","url":null,"abstract":"Abstract Vitamin K antagonists (VKAs) are widely used for the primary and secondary prevention of thromboembolism, their anticoagulant effect being monitored through INR. Achieving and maintaining a stable anticoagulation status is challenging, because of the narrow therapeutic range, and of the extremely variable individual response to therapy. Environmental factors such as age, gender, body mass, diet, herbal supplements, drugs, pre-existing pathology, as well as genetic factors can substantially influence the anticoagulant effect of VKAs. The main genetic factors that contribute to individual variability in response to VKAs are genetic polymorphisms in genes influencing VKAs’ metabolism (CYP2C9) and pharmacodynamic response (VKOR1) and account for about one third in the variation of warfarin and analogues dose requirement. Systematic genotyping of patients requiring warfarin therapy is still a matter of debate. Although novel oral anticoagulants (direct thrombin and factor Xa inhibitors) seem promising, VKAs are still frequently prescribed, therefore physicians should be aware of the various factors influencing VKAs’ effect, and educational programmes for doctors and patients should be conducted in that respect Rezumat Antagoniștii vitaminei K (AVK) sunt utilizați pe scară largă pentru profilaxia primară și secundară a trombembolismului, efectul lor anticoagulant fiind monitorizat prin intermediul INR. Atingerea și menținerea unui status anticoagulant stabil este adesea dificilă din cauza intervalului therapeutic îngust și a variabilității în răspunsul individual la tratament. Factorii de mediu între care vârsta, sexul, greutatea corporală, alimentația, produsele naturiste și suplimentele alimentare, medicamentele și patologia asociată, precum și factorii genetici pot influența substanțial efectul anticoagulant al AVK. Principalii factori genetici care intervin în răspunsul individual variabil sunt polimorfisme ale genelor responsabile de metabolizarea AVK (CYP2C9) și de răspunsul farmacodinamic (VKORC1), aceștia contribuind cu circa o treime la necesarul variabil al dozei de AVK, analiza genotipică sistematică a pacienților necesitând terapie cu AVK fiind însă un subiect controversat. Cu toate că noile anticoagulante orale oferă o alternativă promițătoare, antagoniștii vitaminei K sunt în continuare prescriși pe scară largă, ceea ce subliniază necesitatea cunoașterii de către clinicieni a factorilor care le influențează efectul, precum și importanța educației pacienților","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"161 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114628771","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Performance of an interferon-gamma release assay in the diagnosis of tuberculous meningitis in children / Performanţa testului bazat pe eliberarea interferonului gamma în diagnosticul meningitei tuberculoase la copil","authors":"Olga Adriana Caliman-Sturdza, Doina Mihalache, C. Luca","doi":"10.1515/rrlm-2015-0016","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0016","url":null,"abstract":"Abstract The new immunodiagnostic tests based on the Mycobacterium tuberculosis specific antigen, early secretory antigenic target 6 (ESAT-6) and culture filtrate protein 10 (CFP-10), showed promising results in the diagnosis of tuberculosis infection. However, there are only few studies in the published literature on performance tests in cerebrospinal fluid. We investigated whether a rapid diagnosis of tuberculous meningitis (TBM) could be established by interferon-γ blood and cerebrospinal fluid (CSF) tests in children. We used the QuantiFERON-TB Gold in Tube test (QFT-IT) on blood and the QuantiFERON-TB Gold test (QFT-G) on the CSF of 63 subjects with TBM (including 25 case of definite TBM and 38 cases of probable TBM) and 62 controls. The CSF analyses indicated possible TBM in 63.4% of cases. The sensitivity of the CSF culture for Mycobacterium tuberculosis was only 39.6%. The sensitivity of the tuberculin skin test (TST) was 49.2% and the specificity was 88.6%. The estimated sensitivities of the QFT-G for the CSF and QFT-IT for the blood in culture confirmed TBM cases (gold standard) were 84% and 80%, respectively. The estimated specificities were 98.2% for the CSF and 87.9% for the blood. This study showed that the sensitivity of QFT for the CSF could be higher than TST and culture and slightly higher in CSF than in blood. The specificity of QFT-G for the CSF was higher those of the TST, but the specificity of QFT-IT is lower. QFT-G of the CSF is a useful diagnostic marker of tuberculosis that may improve the management of TBM, but the test results must be correlated with clinical, radiological and characteristics of CSF. New researches are needed to investigate the performance of QFT-G in the CSF compared with ELISPOT and PCR Rezumat Noile teste imunologice bazate pe antigene specifice ale Mycobacterium tuberculosis, ESAT-6 şi CFP-10, au arătat rezultate promiţătoare în diagnosticul tuberculozei. Totuşi, există numai câteva studii in literatură asupra performanţei testelor în lichidul cefalorahidian. În studiul de faţă am investigat posibilitatea unui diagnostic rapid al meningitei tuberculoase (MTB) la copil prin efectuarea testelor bazate pe eliberarea interferonului gamma în sânge și în lichidul cefalorahidian (LCR). Am folosit testul QuantiFERON-TB Gold in Tube (QFT-IT) în sânge şi testul QuantiFERON-TB Gold (QFT-G) în LCR la 63 de subiecţi diagnosticaţi cu MTB (incluzând 25 cazuri definite de MTB şi 38 cazuri de menigită probabil TB) şi 62 cazuri control. Analiza LCR a fost sugestivă pentru o MTB în 63.4% din cazuri. Sensibilitatea culturilor pentru Mycobacterium tuberculosis în LCR a fost de numai 39.6%. Sensibilitatea intradermoreacţiei la tuberculină (IDR) a fost de 49.2% si specificitatea de 88.6%. Sensibiltatea estimată a QFT-G in LCR şi QFT-IT în sânge în cazurile de MTB confirmate prin culturi (standardul de aur) a fost de 84% si respectiv 80%. Specificitatea estimată a fost de 98.2% in LCR şi 87.9% in sânge. Acest studiu a ară","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"128935223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Coronary Sinus Lactate as Marker of Myocardial Ischemia in Cardiac Surgery: Correlation with Morbidity and Mortality after Cardiac Surgery / Lactatul din sinusul coronarian - marker al ischemiei miocardice în chirurgia cardiacă: corelaţii cu morbiditatea şi mortalitatea postoperatorie","authors":"Victor Raicea, Judit Kovacs, L. Moraru, Horaţiu Suciu","doi":"10.1515/rrlm-2015-0019","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0019","url":null,"abstract":"Abstract Introduction. Perioperative myocardial injuries are one of the most frequent causes of morbidity and mortality after cardiac surgery, the most common etiology being the poor myocardial protection during aortic crossclamp. During aortic crossclamp progressive accumulation of lactate and intracellular acidosis are well-known phenomena, and are associated with alteration of myocardial contractile function. Our objective was to study the coronary sinus lactate levels as a predictor of postoperative hemodynamic outcome in open-heart surgical patients. Material and methods. We performed a prospective clinical trial, including 142 adult patients with elective cardiac surgery. Anterograde cardioplegia was administered in 82 patients, retrograde cardioplegia in 60 (in 30 patients it was administrated intermittently and in 30 continuously). Blood was collected simultaneously from the aortic cardioplegic line (inflow) and from coronary sinus or the aortic root (outflow) before aortic crossclamp, after crossclamp at every 10 minutes and after crossclamp removal at 0 and 10 minutes. All patients were operated on cardiopulmonary bypass with cardiac arrest, using warm-blood cardioplegia for cardioprotection. Results. Lactate levels showed increasing values during aortic crossclamp, and a rapid decline after crossclamp removal. The incidence of low cardiac output was significantly higher in patients with lactate levels that exceeded 4 mmol/L. In patients who died in the postoperative period, lactate level was even higher (5 mmol/L), with only a modest recovery after crossclamp removal. Conclusion. Monitoring lactate level in coronary sinus blood is a reliable method and has a good prognostic value regarding postoperative morbidity and mortality in open heart surgery Rezumat Introducere. Leziunile miocardice perioperatorii sunt cauza cea mai frecventă a morbidităţii şi mortalităţii după intervenţii chirurgicale cardiace, cauzele cele mai frecvente fiind protecţia miocardică deficitară din timpul clampajului aortic. În timpul ischemiei miocardice acumularea progresivă de lactat şi acidoza celulară sunt fenomene bine-cunoscute, fiind asociate cu alterarea funcţiei contractile miocardice. Scopul lucrării noastre a fost de a studia eficiența monitorizării nivelului de lactat din sinusul coronarian, ca factor predictiv al evoluţiei hemodinamice postoperatorii la pacientul operat pe cord deschis. Materiale şi metode. Am efectuat un studiu clinic prospectiv, incluzând 142 pacienţi programaţi pentru intervenţie chirurgicală pe cord deschis. Cardioplegia anterogradă a fost administrată la 82 pacienţi, pe cale retrogradă la 60 (din care la 30 pacienţi a fost administrat intermitent, la 30 în mod continuu). Toţi pacienţii au fost operaţi în bypass cardiopulmonar total cu oprire cardiacă, folosind cardioplegie caldă. Am recoltat sânge simultan din linia de cardioplegie (inflow) şi sinusul coronarian sau rădăcina aortei (outflow) înainte de clamparea aortei, imediat ","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"131271849","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Platelet indices in Philadelphia-negative chronic myeloproliferative neoplasms / Indicii plachetari de volum în neoplasmele mieloproliferative cronice Philadelphia-negative","authors":"A. Olteanu, R. Mihăilă, A. Cătană, O. Flucuş, C. Bus, M. Mihalache","doi":"10.1515/rrlm-2015-0012","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0012","url":null,"abstract":"Abstract Introduction: Philadelphia-negative chronic myeloproliferative neoplasms (Ph-MPN): polycythemia vera (PV), essential thrombocythaemia (ET), and primary myelofibrosis (PMF) are characterized by an increased rate of thrombosis complications partly due to platelets activation. Large platelets are more active, have an enhanced procoagulant function and have a pathogenic role in arterial and venous thrombosis. In our study we tried to establish if platelet volume indices (MPV, PDW, P-LCR) issued from automated complete blood count determination are significantly different in Ph-MPN patients in comparison to healthy subjects. Materials and methods: Blood cell counts including platelet volume indices were assessed for 102 Ph-MPN and 102 healthy subjects using the impedance method on Sysmex XS 1000i and glucose and lipid profile, were assessed on Architect c 8000. Assessement of JAK2V617 positivity was conducted with amplification refractory mutation system polymerase chain reaction (ARMS-PCR), in whole peripheral blood. Results: Platelet volume indices (PVI) measured with the impedance based method, did not show significant differences in Ph-MPN patients in comparison to healthy controls. We noticed a moderate correlation between these indices and the presence of JAK2V617F mutation. PVI were increased in the small subgroup of patients treated with anagrelide and decreased in patients treated with simvastatin, comparatively with untreated patients. Conclusion: In our study we did not find a significant difference between platelet volume indices from Ph-MPN patients and healthy subjects. Further studies are required to demonstrate correlations between platelet volume indices and JAK2 V617F mutation, treatment with anagrelide and statins, respectively Rezumat Introducere: Neoplasmele mieloproliferative cronice cromozom Philadelphia negative (Ph-MPN) -policitemia vera (PV), trombocitemia esenţială (TE) şi mielofibroza primară (MP) - sunt caracterizate de o rată mare de complicaţii trombotice, parţial date de activarea trombocitară. Trombocitele mari sunt mai active, cu o funcţie procoagulantă crescută şi au rol patogenic demonstrat în tromboza arterială şi venoasă. În studiul nostru am încercat să stabilim dacă indicii trombocitari (MPV, PDW, P-LCR), furnizaţi de analizoarele de hematologie în hemoleucograma completă, sunt modificaţi la pacienţii diagnosticaţi cu Ph-MPN comparativ cu subiecţii sănătoşi. Material şi metodă: Hemoleucograma, ce a inclus şi indicii trombocitari, a fost determinată la 102 pacienţi Ph- MPN şi la 102 subiecţi sănătoşi cu ajutorul analizorului de hematologie Sysmex XS 1000i (metoda impedanţei), iar testele biochimice (glucoza şi parametrii metabolismului lipidic), pe analizorul Architect c8000. Prezenţa mutaţiei JAK2 V617F, la pacienţii cu Ph-MPN, a fost evidenţiată prin tehnica ARMS-PCR. Rezultate: Indicii de volum plachetari (IVP) măsuraţi prin metoda impedanţei, nu au fost semnificativ modificaţi la pacienţii cu Ph-MPN ","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"56 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133687232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"From primer design to validation of results - is it possible by using free software only? / De la proiectarea primerilor la validarea rezultatelor - este posibil utilizând doar programe gratuite?","authors":"Adrian Man, Claudia Bănescu, Minodora Dobreanu, Cornel Fraefel","doi":"10.1515/RRLM-2015-0022","DOIUrl":"https://doi.org/10.1515/RRLM-2015-0022","url":null,"abstract":"Abstract Successful experiments in molecular biology require good knowledge about various methods and protocols. In molecular biology, nucleic acid manipulation is the essence, starting with the quality of extraction and ending with several analysis assays (PCR, RT-PCR, qPCR, PCR arrays, molecular cloning, etc). Though many of these are so called “standardized”, in practice there are many variables that can influence the outcome of the experiment. Due to the importance of optimal primer design in PCR assays, we will focus on primer designing and checking software, but we also present other useful free tools that can help researchers in the molecular biology field Rezumat Pentru a avea succes în experimentele de biologie moleculară, sunt necesare cunoștințe bune despre diversele metode și protocoale în acest domeniu. În biologia moleculară, manipularea corespunzătoare a acizilor nucleici este esențială, începând cu calitatea extracției până la testele efective (PCR, RT-PCR, qPCR, PCR array, clonare, etc). Deși multe dintre protocoale sunt “standardizate”, în practică sunt multe variabile care pot influența rezultatele experimentelor. Datorită importanței proiectării corecte a primerilor în metodele de tip PCR, ne vom concentra pe modul de proiectare și pe verificarea lor cu ajutorul programelor de calculator, dar de asemenea prezentăm și alte programe utile disponibile gratuit, care pot ajuta cercetătorii în domeniul biologiei moleculare","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"1 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"124353275","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Severe infections in kidney transplanted children","authors":"A. Bizo, Bogdan Bulata","doi":"10.1515/rrlm-2015-0020","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0020","url":null,"abstract":"","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"29 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"122234938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Two Hypospadias Cases in a Family with Translocation Involving Chromosomes X and 21","authors":"I. Pașcanu, C. Bănescu, Simona Huțu, H. Gozar, R. Neagoe","doi":"10.1515/rrlm-2015-0018","DOIUrl":"https://doi.org/10.1515/rrlm-2015-0018","url":null,"abstract":"","PeriodicalId":288498,"journal":{"name":"Romanian Review of Laboratory Medicine","volume":"17 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"133739638","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}